Margaret Hamburg

She is married to Peter Fitzhugh Brown, a computer scientist and artificial intelligence expert. Brown is the chief executive officer of Renaissance Technologies. Renaissance Technologies was the top donor to President Donald Trump's 2016 campaign and the third largest donor to Hillary Clinton, giving $15.5 million and $16.5 million respectively.

Forbes named her as one of the world's 100 most powerful women multiple times, most recently in 2014 (#51).

Hamburg has received numerous awards, among them the National Consumers League's Trumpeter Award in 2011 and the National Center for Health Research's 2011 Health Research Policy Hero Award. She has also received the American College of Clinical Pharmacology's (ACCP) Nathaniel T. Kwit Memorial Distinguished Service Award, the New York Academy of Medicine Medal for Distinguished Contributions in Health Policy, the Radcliffe Alumnae Award and the American Lung Association's Breath of Life Award. Hamburg was the 2017 recipient of the FDAAA's Harvey W. Wiley Lecture Award for Outstanding Leadership in Advancing Public Health.

Hamburg was nominated by President Barack Obama in March 2009 to become Commissioner of the Food and Drug Administration, and was unanimously confirmed in May 2009. As FDA Commissioner she was known for advancing regulatory science, streamlining and modernizing FDA's regulatory pathways, and globalization of the agency, as well as the implementation of the Family Smoking Prevention and Tobacco Control Act (2009), the Food Safety Modernization Act (2011), and a review of the system for the evaluation and approval of medical devices.

In 1997, President Bill Clinton appointed Hamburg as Assistant Secretary for Planning and Evaluation at the U.S. Department of Health and Human Services. She served in this policy role until 2001 when she became the founding Vice President for Biological Programs and later the Senior Scientist for the Nuclear Threat Initiative, a foundation dedicated to reducing the threat to public safety from nuclear, chemical, and biological weapons. In that role, Hamburg spearheaded efforts to prevent, detect, and respond to both naturally occurring and deliberately caused biological threats.

Following her medical training, Hamburg moved to Washington, D.C., to begin her career in public service. She served in several roles, including Assistant Director of the National Institute of Allergy and Infectious Diseases, National Institutes of Health. In 1991 Hamburg was appointed Commissioner of the New York City Department of Health and Mental Hygiene, where she served for six years, working first for Mayor David Dinkins and then-Mayor Rudy Giuliani. During her tenure, she worked on improved services for women and children, a needle-exchange program to reduce HIV transmission, a program to curtail the resurgence and spread of tuberculosis, and the nation's first public health bioterrorism preparedness program.

Hamburg is the daughter of Beatrix Hamburg and David A. Hamburg, both physicians. Her mother was the first self-identified African-American woman to be accepted at Vassar College and to earn a degree from the Yale University School of Medicine. Her father is President Emeritus of the Carnegie Corporation of New York and also served as the president of the AAAS in 1984.

Hamburg graduated from Harvard College in 1977 and earned her M.D. from Harvard Medical School in 1983. She completed her medical residency training at the New York Hospital-Cornell Medical Center and is Board Certified in Internal Medicine. In April 2015 she was appointed Foreign Secretary of the National Academy of Medicine. In December 2016, Hamburg was named president-elect for the AAAS. She serves a three-year term as an officer and member of the Executive Committee of the AAAS Board of Directors beginning in February 2017.

Margaret Ann "Peggy" Hamburg (born July 12, 1955, Chicago, Illinois) is an American physician and public health administrator, who is serving as the Chair of the Board of the American Association for the Advancement of Science (AAAS). She served as the 21st Commissioner of the U.S. Food and Drug Administration from May 2009 to April 2015.